Item 4, purpose of the transaction:Item 4 of this Amendment is supplemented and amended, as the case may be, as follows: On September 14, 2026, the Adviser exercised options to purchase Ordinary Shares or ADS ("Share Options") to purchase 30,768 ADS as a result of the exercise of 15,384 Share Options to purchase ADS at $36.83 per ADS (the "Exercised ADS Options") held directly by each of Ranjeev Krishana and Michael Goller, resulting in the acquisition of a total of 30,768 ADS. Messrs. Krishana and Goller, each of whom is a full-time employee of the Adviser, previously served on the Issuer's board of directors (the "Board") as representatives of the Funds. The policy of the Funds and the Adviser does not permit full-time em…Read the filing
BeOne Medicines Ltd. ONC
Institutional owners are on their way
13F data can be up to 45 days oldWe read every 13F filing after each quarter ends. The owners of ONC show here after the next update.
Institutional ownership
Institutional owners
Institutional owners are on their wayWe read every 13F filing after each quarter ends. The owners of ONC show here after the next update.
Funds that hold ONC
Mutual funds and ETFs, each from its own latest portfolio report. Funds report on their own quarter ends.
Fund holdings are on their wayWe read the funds' N-PORT reports after each quarter. The funds that hold ONC show here after the next update.
Superinvestors holding ONC
The investors followed on Tickdelta, from their latest 13F.
None of the followed investors held ONC in their latest 13F.
Sold out last quarter: Zhang Lei
13D filings: owners who may push for change
Owners of more than 5%
Item 4, purpose of the transaction:On June 11, 2026, Felix J. Baker, Ph.D., a managing member of the Adviser GP, was elected to the board of directors of the Issuer (the "Board") to serve as a director of the Issuer until the completion of the Issuer's 2027 annual general meeting of shareholders, subject to his earlier resignation or removal. Dr. Baker serves as the Lead Director of the Issuer. Michael Goller and Ranjeev Krishana, both previous directors of the Issuer and both of whom are employees of the Adviser, did not stand for re-election to the Board, and as a result their service on the Board automatically expired on June 11, 2026, the date of the Issuer's 2026 annual general meeting of shareholders. In conjunction w…Read the filing
Item 4, purpose of the transaction:On April 16, 2026, the Issuer filed a Preliminary Proxy Statement disclosing that Felix J. Baker, Ph.D., a managing member of the Adviser GP, was nominated by the board of directors of the Issuer (the "Board") to serve as a director of the Issuer until the completion of the Issuer's 2027 annual general meeting of shareholders, subject to his earlier resignation or removal. If elected, Dr. Baker will serve as the Lead Director of the Issuer. Michael Goller, a director of the Issuer, and Ranjeev Krishana, a director of the Issuer and the Issuer's current Lead Director, both of whom are employees of the Adviser, are not standing for re-election to the Board and it is anticipated that their se…Read the filing
Sources
SEC's Form 13F data sets, each quarter; Form N-PORT data sets for the funds; Schedule 13D filings.
Also
Investors: the portfolios of the superinvestors followed here. Insider trades: what the company's own people bought and sold.